We engineered a probiotic, releasing a microbial peptide, that locally elevates GLP-1, which normalized gut parameters in fiber-deprived mice and alleviated colitis via GLP-1–dependent mechanisms, including improved metabolism, antimicrobial defenses , and barrier restoration. The gene discussed is GCG; the disease is colitis.